GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroScientific Corp (HKSE:02172) » Definitions » Cash, Cash Equivalents, Marketable Securities

MicroPort NeuroScientific (HKSE:02172) Cash, Cash Equivalents, Marketable Securities : HK$1,062.4 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroScientific Cash, Cash Equivalents, Marketable Securities?

MicroPort NeuroScientific's quarterly cash, cash equivalents, marketable securities declined from Dec. 2023 (HK$1,098.90 Mil) to Jun. 2024 (HK$1,073.23 Mil) but then stayed the same from Jun. 2024 (HK$1,073.23 Mil) to Dec. 2024 (HK$1,062.40 Mil).

MicroPort NeuroScientific's annual cash, cash equivalents, marketable securities declined from Dec. 2022 (HK$1,221.67 Mil) to Dec. 2023 (HK$1,098.90 Mil) and declined from Dec. 2023 (HK$1,098.90 Mil) to Dec. 2024 (HK$1,062.40 Mil).


MicroPort NeuroScientific Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for MicroPort NeuroScientific's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroScientific Cash, Cash Equivalents, Marketable Securities Chart

MicroPort NeuroScientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 504.39 726.46 1,221.67 1,098.90 1,062.40

MicroPort NeuroScientific Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,221.67 1,262.21 1,098.90 1,073.23 1,062.40

MicroPort NeuroScientific Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


MicroPort NeuroScientific  (HKSE:02172) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


MicroPort NeuroScientific Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroScientific's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroScientific Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai, CHN
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region.
Executives
Microport Scientific Corporation
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroScientific Headlines

No Headlines